The invention is directed to an ophthalmic composition adapted for topical once-a-day administration to the eye comprising an ophthalmic drug, in particular to an ophthalmic composition comprising an ophthalmic drug and at least one polymer selected from one or more of i) a polyoxyethylene-polyoxypropylene co-polymer or block co-polymer, and ii) a cross-linked acrylic acid polymer.
申请公布号
WO02100436(A3)
申请公布日期
2003.09.25
申请号
WO2002EP06282
申请日期
2002.06.07
申请人
NOVARTIS AG;NOVARTIS PHARMA GMBH;BABIOLE SAUNIER, MAGGY;BIZEC, JEAN-CLAUDE;FETZ, ANDREA;SCHOCH, CHRISTIAN
发明人
BABIOLE SAUNIER, MAGGY;BIZEC, JEAN-CLAUDE;FETZ, ANDREA;SCHOCH, CHRISTIAN